nasdaq:mygn
|
11901
|
Apr 14th, 2024 12:00AM
|
Myriad Genetics
|
79K
|
2549
|
Open
|
|
Apr 13th, 2024 11:24PM
|
Apr 13th, 2024 11:24PM
|
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
Open
|
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
|
Open
|
322 N 2200 W
|
Salt Lake City
|
Utah
|
US
|
84116
|
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
11901
|
Apr 13th, 2024 12:00AM
|
Myriad Genetics
|
79K
|
2547
|
Open
|
|
Apr 12th, 2024 11:16PM
|
Apr 13th, 2024 11:50AM
|
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
Open
|
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
|
Open
|
322 N 2200 W
|
Salt Lake City
|
Utah
|
US
|
84116
|
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
11901
|
Apr 12th, 2024 12:00AM
|
Myriad Genetics
|
79K
|
2549
|
Open
|
|
Apr 11th, 2024 11:21PM
|
Apr 12th, 2024 08:45AM
|
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
Open
|
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
|
Open
|
322 N 2200 W
|
Salt Lake City
|
Utah
|
US
|
84116
|
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
11901
|
Apr 11th, 2024 12:00AM
|
Myriad Genetics
|
79K
|
2549
|
Open
|
|
Apr 10th, 2024 11:54PM
|
Apr 11th, 2024 11:30AM
|
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
Open
|
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
|
Open
|
322 N 2200 W
|
Salt Lake City
|
Utah
|
US
|
84116
|
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
11901
|
Apr 10th, 2024 12:00AM
|
Myriad Genetics
|
78K
|
2549
|
Open
|
|
Apr 9th, 2024 11:24PM
|
Apr 10th, 2024 05:38PM
|
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
Open
|
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
|
Open
|
322 N 2200 W
|
Salt Lake City
|
Utah
|
US
|
84116
|
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
11901
|
Apr 9th, 2024 12:00AM
|
Myriad Genetics
|
78K
|
2547
|
Open
|
|
Apr 8th, 2024 11:34PM
|
Apr 9th, 2024 10:19AM
|
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
Open
|
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
|
Open
|
322 N 2200 W
|
Salt Lake City
|
Utah
|
US
|
84116
|
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
11901
|
Apr 8th, 2024 12:00AM
|
Myriad Genetics
|
78K
|
2546
|
Open
|
|
Apr 7th, 2024 11:59PM
|
Apr 8th, 2024 07:17PM
|
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
Open
|
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
|
Open
|
322 N 2200 W
|
Salt Lake City
|
Utah
|
US
|
84116
|
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
11901
|
Apr 7th, 2024 12:00AM
|
Myriad Genetics
|
78K
|
2551
|
Open
|
|
Apr 6th, 2024 11:30PM
|
Apr 6th, 2024 11:30PM
|
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
Open
|
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
|
Open
|
322 N 2200 W
|
Salt Lake City
|
Utah
|
US
|
84116
|
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
11901
|
Apr 6th, 2024 12:00AM
|
Myriad Genetics
|
78K
|
2551
|
Open
|
|
Apr 5th, 2024 11:30PM
|
Apr 5th, 2024 11:30PM
|
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
Open
|
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
|
Open
|
322 N 2200 W
|
Salt Lake City
|
Utah
|
US
|
84116
|
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
11901
|
Apr 5th, 2024 12:00AM
|
Myriad Genetics
|
78K
|
2543
|
Open
|
|
Apr 4th, 2024 11:58PM
|
Apr 4th, 2024 11:58PM
|
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
Open
|
Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
|
Open
|
322 N 2200 W
|
Salt Lake City
|
Utah
|
US
|
84116
|
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|